RMP
OGN icon

Richards, Merrill & Peterson’s Organon & Co OGN Stock Holding History

Richards, Merrill & Peterson’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,500
Closed -$67K – 388
2025
Q1 		$67K Hold
4,500
– – 0.03% 225
2024
Q4 		$67.1K Buy
+4,500
New +$73.3K 0.04% 216

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Richards, Merrill & Peterson's OGN Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 4,500 shares — an estimated $67K sold.

Richards, Merrill & Peterson first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $67.1K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 4,500 Organon & Co shares in Q2 2025, an estimated $67K.
  • Richards, Merrill & Peterson first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
  • Richards, Merrill & Peterson's Organon & Co position peaked at $67.1K in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.